BSX
Boston Scientific Corporation
- Depreciation and amortization, 2025
- $1.4B
- YoY, 2025
- +7.8%
- 5-year CAGR
- +4.0%
- 10-year CAGR
- +5.9%
Depreciation and amortization
Depreciation and amortization by fiscal year
| Period | D&A | YoY |
|---|---|---|
| 2025 | $1.4B | +7.8% |
| 2024 | $1.3B | +6.1% |
| 2023 | $1.2B | +5.3% |
| 2022 | $1.1B | +3.9% |
| 2021 | $1.1B | −2.7% |
| 2020 | $1.1B | +11.2% |
| 2019 | $1.0B | +12.8% |
| 2018 | $895M | +6.0% |
| 2017 | $844M | +3.6% |
| 2016 | $815M | +6.0% |
| 2015 | $769M | +6.1% |
| 2014 | $725M | +5.2% |
| 2013 | $689M | +0.9% |
| 2012 | $683M | −4.7% |
| 2011 | $717M | −12.1% |
| 2010 | $816M | −2.2% |
| 2009 | $834M | −3.5% |
| 2008 | $864M | −5.9% |
| 2007 | $918M | — |